November 2023 has been tumultuous, and as such, navigating through the myriad of critical issues can be a daunting task, especially to create a global health summary.  However, we have picked a few core issues shaping our world.


In the latest global health updates, the World Health Organization (WHO) casts a spotlight on the escalating prevalence of diabetes, emphasising its disproportionate rise in low- and middle-income countries. The WHO further provides critical insights into the sudden onset of diabetes symptoms, underscoring the urgency for awareness and early detection.

Read the article 

Dengue Risks

Shifting our focus to Mexico, an alarming spike in Dengue cases takes centre stage. According to the Mexican Health Ministry’s latest report, confirmed cases of Dengue have skyrocketed by a staggering 337% this year. The International Travel & Health Insurance Journal (ITIJ) sheds light on this concerning development.

Read the article 

Meanwhile, the NHS contributes to the global health discourse by sharing crucial insights on malaria risk reduction. Focusing on the particularly severe ‘Falciparum’ malaria, the NHS has unveiled key prevention and detection tips, adding valuable knowledge to the ongoing efforts to combat this life-threatening infection.

New Diagnostics List 

Shifting gears, the WHO releases its highly anticipated 2023 Essential Diagnostics List (EDL), a comprehensive register of in vitro diagnostics (IVD) designed to guide countries in making informed diagnostic choices. This evidence-based list plays a crucial role in supporting national healthcare systems.

This year’s EDL introduces two noteworthy additions:

  1. Hepatitis E Virus (HEV) Tests: The list now includes three tests for the hepatitis E virus, including a rapid diagnostic tool aimed at facilitating the swift diagnosis and surveillance of HEV infections. This signifies a significant step forward in addressing the diagnostic needs associated with this viral infection.
  2. Personal Use Glucose Monitoring Devices: In a groundbreaking move, the WHO advises the inclusion of personal use glucose monitoring devices in addition to the existing medical recommendations for diabetes. This recognition acknowledges the importance of empowering individuals in managing their diabetes through accessible and user-friendly monitoring tools.

Read the article 

As we navigate the evolving landscape of health concerns in November 2023, these updates are just a few global health challenges and changes. As always, we recommend the following sites for up to  date information.